Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

CAS No. 96680-77-2

2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one( —— )

Catalog No. M28385 CAS No. 96680-77-2

2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    2-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • Description
    2-methyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one is ligand of CBP.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Human Endogenous Metabolite|GPR109B|AhR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    96680-77-2
  • Formula Weight
    193.26
  • Molecular Formula
    C10H11NOS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1CC(=O)Nc2ccccc2S1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang XD, et al. A method for the determination of D-kynurenine in biological tissues. Anal Bioanal Chem. 2013 Dec;405(30):9747-54.
molnova catalog
related products
  • BRD7-IN-1

    BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .

  • OXFBD04

    OXFBD04 is a potent and selective inhibitor of BRD4(IC50 of 166 nM).

  • GSK778

    GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). GSK778 inhibits proliferation, induces a cell cycle arrest and apoptosis.